Bipolar Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who score in the clinical range for depression on a standard self-report questionnaire called the PHQ-9
- People who have been diagnosed with depression based on a structured diagnostic interview called the DIAMOND
- People who have been diagnosed with Bipolar I or Bipolar II Disorder using the DIAMOND diagnostic interview
- People who have a working knowledge of written and spoken Icelandic, sufficient to participate in therapy and complete study assessments without needing a translator
Who may not be able to join:
- People who have a current or past learning disability, brain injury or condition affecting brain function, or a dependence on drugs or alcohol that could affect their ability to engage with therapy
- People who are currently at significant risk of self-harm or suicide that the trial site determines cannot be safely managed at the Bipolar outpatient clinic at Landspitali
- People who do not currently have the capacity to give informed consent to participate
- People who are currently receiving another form of psychological or talking therapy for depression or bipolar disorder
- People whose treating clinician and therapist consider another condition — such as Post-Traumatic Stress Disorder or psychosis — to be the more important focus of treatment at this time
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Brynja B Magnúsdóttir, PhD, Reykjavik University
Phone: 8688371
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Minimally clinically significant improvement in depression symptoms for a majority of participants (>60%); Therapy uptake rate; Therapy completion rate; Change in activity levels as measured by consumer connected health devices; Change in Sleep Duration measured by health device; No significant adverse reaction for participants
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.